Kisspeptin for testosterone: what the studies actually show

What's this video probably claiming?

Based on the caption and hashtags, this creator is almost certainly pitching kisspeptin as a testosterone-boosting peptide worth trying for muscle gain, fat loss, or anti-aging. The framing, "อยากเพิ่ม test ใช้ kisspeptin ดีจริงมั้ย" (roughly: want to raise testosterone, is kisspeptin actually good?), suggests the video positions this neuropeptide as a practical tool rather than a research compound. Given the hashtag cluster around fitness, weight loss, and erectile function (เสื่อมสมรรถภาพ), the implied audience is men looking for alternatives to TRT or add-ons that might amplify androgen output without injecting testosterone directly. That framing is common in Thai-language peptide content, and it tends to compress a genuinely complex neuroendocrine story into a much tidier narrative than the evidence supports.

What does the science actually show?

Kisspeptin is a real neuropeptide encoded by the KISS1 gene. It acts on GnRH neurons in the hypothalamus, triggering a downstream pulse of LH and FSH, which does stimulate testicular testosterone production. That mechanism is not invented. Dhillo et al. (2005, Journal of Clinical Endocrinology and Metabolism) showed that IV kisspeptin-54 at 1 nmol/kg significantly elevated LH in healthy men. More recent work by Abbara et al. (2020, Journal of Clinical Investigation) confirmed that kisspeptin-54 infusion restored pulsatile LH secretion in men with hypogonadotropic hypogonadism. The catch: these were controlled IV infusions under clinical supervision, not subcutaneous self-injection protocols. Oral bioavailability is negligible. Subcutaneous data in humans is sparse. The testosterone elevations seen are transient and highly context-dependent, not the sustained anabolic lift the fitness hashtags imply.

Where does the social media noise diverge from clinical reality?

Several gaps matter here. First, tachyphylaxis: continuous kisspeptin exposure desensitizes GnRH receptors, which can paradoxically suppress LH. Skorupskaite et al. (2014, Human Reproduction Update) documented this clearly in women, and the principle applies across sexes. So the "more is better" logic that circulates in peptide communities is pharmacologically backwards for this compound. Second, the fitness hashtags imply body composition benefits, but there is no human RCT linking kisspeptin administration to measurable changes in lean mass or fat percentage. Third, the erectile dysfunction hashtag (เสื่อมสมรรถภาพ) likely references Wyatt et al. (2023, NEJM Evidence), which showed kisspeptin improved sexual brain processing, but that study was conducted in a clinical setting with specific patient selection, not as a general male enhancement protocol.

What should you actually know?

Kisspeptin research is genuinely interesting and moving fast, but the clinical gap between "mechanistically plausible" and "proven to work as a self-administered peptide" is enormous. The compound is not approved by any major regulatory body for testosterone optimization or body composition. Compounded kisspeptin products, if they exist in the Thai market, have no standardized purity benchmarks. Dosing, injection timing, and pulse frequency all matter enormously given the desensitization risk, and getting those wrong could suppress the HPG axis rather than stimulate it. If you have documented hypogonadotropic hypogonadism, this is a conversation worth having with an endocrinologist who has access to the actual clinical literature. If you are a healthy male trying to add muscle, there is currently no evidence kisspeptin moves the needle on body composition at all.